|
1
|
Mahalingam R, Wellish M, Wolf W, Dueland
AN, Cohrs R, Vafai A and Gilden D: Latent varicella-zoster viral
DNA in human trigeminal and thoracic ganglia. N Engl J Med.
323:627–631. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pope JE, Krizova A, Ouimet JM, Goodwin JL
and Lankin M: Close association of herpes zoster reactivation and
systemic lupus erythematosus (SLE) diagnosis: Case-control study of
patients with SLE or noninflammatory nusculoskeletal disorders. J
Rheumatol. 31:274–279. 2004.PubMed/NCBI
|
|
3
|
Yawn BP, Saddier P, Wollan PC, St Sauver
JL, Kurland MJ and Sy LS: A population-based study of the incidence
and complication rates of herpes zoster before zoster vaccine
introduction. Mayo Clin Proc. 82:1341–1349. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Borba EF, Ribeiro AC, Martin P, Costa LP,
Guedes LK and Bonfá E: Incidence, risk factors, and outcome of
Herpes zoster in systemic lupus erythematosus. J Clin Rheumatol.
16:119–122. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chakravarty EF, Michaud K, Katz R and
Wolfe F: Increased incidence of herpes zoster among patients with
systemic lupus erythematosus. Lupus. 22:238–244. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ishikawa O, Abe M and Miyachi Y: Herpes
zoster in Japanese patients with systemic lupus erythematosus. Clin
Exp Dermatol. 24:327–328. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sayeeda A, Al Arfaj H, Khalil N and Al
Arfaj AS: Herpes Zoster infections in SLE in a university hospital
in Saudi Arabia: Risk factors and outcomes. Autoimmune Dis.
2010:1748912010.
|
|
8
|
Oomatia A, Fang H, Petri M and Birnbaum J:
Peripheral neuropathies in systemic lupus erythematosus (SLE):
Clinical features, disease associations, and immunological
characteristics evaluated over a 25-year study period. Arthritis
Rheumatol. 66:1000–1009. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee PP, Lee TL, Ho MH, Wong WH and Lau YL:
Herpes zoster in juvenile-onset systemic lupus erythematosus:
Incidence, clinical characteristics and risk factors. Pediatr
Infect Dis J. 25:728–732. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guthridge JM, Cogman A, Merrill JT,
Macwana S, Bean KM, Powe T, Roberts V, James JA and Chakravarty EF:
Herpes zoster vaccination in SLE: A pilot study of immunogenicity.
J Rheumatol. 40:1875–1880. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kimberlin DW and Whitley RJ:
Varicella-zoster vaccine for the prevention of herpes zoster. N
Engl J Med. 356:1338–1343. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Singh JA, Furst DE, Bharat A, Curtis JR,
Kavanaugh AF, Kremer JM, Moreland LW, O'Dell J, Winthrop KL,
Beukelman T, et al: 2012 update of the 2008 American College of
Rheumatology recommendations for the use of disease-modifying
antirheumatic drugs and biologic agents in the treatment of
rheumatoid arthritis. Arthritis Care Res (Hoboken). 64:625–639.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Papadopoulou D and Sipsas NV: Comparison
of national clinical practice guidelines and recommendations on
vaccination of adult patients with autoimmune rheumatic diseases.
Rheumatol Int. 34:151–163. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu SA, Yeh KW, Yao TC and Huang JL:
Association of herpes zoster infection with clinical
characteristics and MBL2 gene polymorphisms in Chinese children
with systemic lupus erythematosus. Pediatr Infect Dis J.
30:656–660. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hu SC, Lin CL, Lu YW, Chen GS, Yu HS, Wu
CS and Lan CC: Lymphopaenia, anti-Ro/anti-RNP autoantibodies, renal
involvement and cyclophosphamide use correlate with increased risk
of herpes zoster in patients with systemic lupus erythematosus.
Acta Derm Venereol. 93:314–318. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Eilertsen GØ, Becker-Merok A and Nossent
JC: The influence of the 1997 updated classification criteria for
systemic lupus erythematosus: Epidemiology, disease presentation,
and patient management. J Rheumatol. 36:552–559. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cohen JI: Clinical practice: Herpes
zoster. N Engl J Med. 369:255–263. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bombardier C, Gladman DD, Urowitz MB,
Caron D and Chang CH: Derivation of the SLEDAI. A disease activity
index for lupus patients. The committee on prognosis studies in
SLE. Arthritis Rheum. 35:630–640. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brisson M, Edmunds WJ, Law B, Gay NJ,
Walld R, Brownell M, Roos LL and De Serres G: Epidemiology of
varicella zoster virus infection in Canada and the United Kingdom.
Epidemiol Infect. 127:305–314. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sisó A, Ramos-Casals M, Bové A,
Brito-Zerón P, Soria N, Muñoz S, Testi A, Plaza J, Sentís J and
Coca A: Previous antimalarial therapy in patients diagnosed with
lupus nephritis: Influence on outcomes and survival. Lupus.
17:281–288. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ruiz-Irastorza G, Olivares N, Ruiz-Arruza
I, Martinez-Berriotxoa A, Egurbide MV and Aguirre C: Predictors of
major infections in systemic lupus erythematosus. Arthritis Res
Ther. 11:R1092009. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nagasawa K, Yamauchi Y, Tada Y, Kusaba T,
Niho Y and Yoshikawa H: High incidence of herpes zoster in patients
with systemic lupus erythematosus: An immunological analysis. Ann
Rheum Dis. 49:630–633. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Straus SE, Ostrove JM, Inchauspé G, Felser
JM, Freifeld A, Croen KD and Sawyer MH: NIH conference.
Varicella-zoster virus infections. Biology, natural history,
treatment, and prevention. Ann Intern Med. 108:221–237. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Carroll S, Gater A, Abetz-Webb L, Smith F,
Demuth D and Mannan A: Challenges in quantifying the
patient-reported burden of herpes zoster and post-herpetic
neuralgia in the UK: Learnings from the Zoster Quality of Life
(ZQOL) study. BMC Res Notes. 6:4862013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Manzi S, Kuller LH, Kutzer J, Pazin GJ,
Sinacore J, Medsger TA Jr and Ramsey-Goldman R: Herpes zoster in
systemic lupus erythematosus. J Rheumatol. 22:1254–1258.
1995.PubMed/NCBI
|
|
26
|
Ng WL, Chu CM, Wu AK, Cheng VC and Yuen
KY: Lymphopenia at presentation is associated with increased risk
of infections in patients with systemic lupus erythematosus. QJM.
99:37–47. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Park HB, Kim KC, Park JH, Kang TY, Lee HS,
Kim TH, Jun JB, Bae SC, Yoo DH, Craft J and Jung S: Association of
reduced CD4 T cell responses specific to varicella zoster virus
with high incidence of herpes zoster in patients with systemic
lupus erythematosus. J Rheumatol. 31:2151–2155. 2004.PubMed/NCBI
|
|
28
|
Cohen EJ: Prevention of herpes zoster: We
need to do better. JAMA Ophthalmol. 131:396–398. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Levin MJ, Smith JG, Kaufhold RM, Barber D,
Hayward AR, Chan CY, Chan IS, Li DJ, Wang W, Keller PM, et al:
Decline in varicella-zoster virus (VZV)-specific cell-mediated
immunity with increasing age and boosting with a high-dose VZV
vaccine. J Infect Dis. 188:1336–1344. 2003. View Article : Google Scholar : PubMed/NCBI
|
